P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD

• Alfonso Piciocchi,
• Giovanni Marconi,
• Marta Cipriani,
• Monica Messina,
• Fabio Guolo,
• Paola Minetto,
• Francesca Paoloni,
• Francesca Cotugno,
• Laura DI Donato,
• Giorgia Simonetti,
• Raffaele Palmieri,
• Francesco Buccisano,
• Paola Fazi,
• Marco Vignetti,
• Roberto M. Lemoni,
• Adriano Venditti,
• Giovanni Martinelli

Affiliations

Alfonso Piciocchi

1 GIMEMA Foundation, Rome, Italy

Giovanni Marconi

2 Hematology Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori, Meldola, Italy

Marta Cipriani

1 GIMEMA Foundation, Rome, Italy

Monica Messina

1 GIMEMA Foundation, Rome, Italy

Fabio Guolo

4 Department of Internal Medicine (Di.M.I.) University of Genoa, Genoa, Italy

Paola Minetto

4 Department of Internal Medicine (Di.M.I.) University of Genoa, Genoa, Italy

Francesca Paoloni

1 GIMEMA Foundation, Rome, Italy

Francesca Cotugno

1 GIMEMA Foundation, Rome, Italy

Laura DI Donato

1 GIMEMA Foundation, Rome, Italy

Giorgia Simonetti

5 Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”,, Meldola, Italy

Raffaele Palmieri

6 Division of Hematology, Tor Vergata Foundation Polyclinic, Rome, Italy; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy

Francesco Buccisano

6 Division of Hematology, Tor Vergata Foundation Polyclinic, Rome, Italy; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy

Paola Fazi

1 GIMEMA Foundation, Rome, Italy

Marco Vignetti

1 GIMEMA Foundation, Rome, Italy

Roberto M. Lemoni

4 Department of Internal Medicine (Di.M.I.) University of Genoa, Genoa, Italy

Adriano Venditti

6 Division of Hematology, Tor Vergata Foundation Polyclinic, Rome, Italy; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy

Giovanni Martinelli

7 IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy